"Phase IIa Trial of Trastuzumab Emtansine with Pertuzumab for Patients with Human Epidermal Growth Factor Receptor 2-positive, Locally Advanced, or Metastatic Breast Cancer" by Reshma Mahtani

Article

Phase IIa Trial of Trastuzumab Emtansine with Pertuzumab for Patients with Human Epidermal Growth Factor Receptor 2-positive, Locally Advanced, or Metastatic Breast Cancer

Journal of Clinical Oncology (2014)

Reshma Mahtani, Baptist Health South Florida
Kathy Miller
Véronique Diéras
Nadia Harbeck
Fabrice Andre
Luca Gianni
Kathy S. Albain, Loyola University Chicago
Diana Crivellar
Liang Fang
Glenn Michelson
Sanne L. de Haas
Howard Burris

Link

Disciplines

Medicine and Health Sciences

Publication Date

May 10, 2014

Citation Information

Reshma Mahtani, Kathy Miller, Véronique Diéras, Nadia Harbeck, et al.. "Phase IIa Trial of Trastuzumab Emtansine with Pertuzumab for Patients with Human Epidermal Growth Factor Receptor 2-positive, Locally Advanced, or Metastatic Breast Cancer" Journal of Clinical Oncology Vol. 21 Iss. 14 (2014)
Available at: http://works.bepress.com/reshma-mahtani/78/